LFA
TECH icon

LGT Financial Advisors’s Bio-Techne TECH Stock Holding History

LGT Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$154 – 617
2025
Q2 		$154 Buy
+3
New +$151 ﹤0.01% 559
2025
Q1 		– Sell
-316
Closed -$22.8K – 680
2024
Q4 		$22.8K Hold
316
– – 0.05% 287
2024
Q3 		$25.3K Hold
316
– – 0.06% 233
2024
Q2 		$22.6K Hold
316
– – 0.05% 279
2024
Q1 		$22.2K Hold
316
– – 0.03% 345
2023
Q4 		$24.4K Sell
316
-8
-2% -$527 0.03% 308
2023
Q3 		$22.1K Buy
+324
New +$25.6K 0.03% 319

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

LGT Financial Advisors's TECH Position: Q3 2025 in Review

LGT Financial Advisors sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 3 shares — an estimated $154 sold.

LGT Financial Advisors first reported a position in TECH in Q3 2023 and held it in 7 quarters. The position peaked at $25.3K in Q3 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • LGT Financial Advisors reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 3 Bio-Techne shares in Q3 2025, an estimated $154.
  • LGT Financial Advisors first reported a position in Bio-Techne in Q3 2023 and held it in 7 quarters.
  • LGT Financial Advisors's Bio-Techne position peaked at $25.3K in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on LGT Financial Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.